Arrow-Trerotola PTD Percutaneous Thrombolytic Device image

Arrow-Trerotola PTD Percutaneous Thrombolytic Device

Proven mechanical thrombectomy technology available for dialysis access

To achieve fast, easy removal of thrombus from both dialysis native AV fistulae and synthetic graft walls, depend on the Arrow-Trerotola PTD Device from Teleflex.

Arrow-Trerotola PTD image


Easy to assemble. Easy to operate. The Arrow-Trerotola PTD Device comes complete with mechanical thrombectomy catheter, hand-held disposable rotator drive unit and introducer sheath. There is no bulky, expensive capital equipment to purchase.


Addresses key benchmarks for effective outcomes, including KDOQI guidelines for both immediate and three-month fistula and graft patency and functionality rates.1-4

Dialysis Access


Technical Patency Rate

3-month Primary Patency Rate

KDOQI Guideline1






Modified Technique3



Use of PTD and Native Fistulae4




The proprietary spinning basket is designed to conform to AV graft and AV fistulae walls for removal of clots with minimal risk of wall damage, and without the use of thrombolytics.5 The basket can also be used for the removal of arterial plugs.3

AV Fistulae

assessment of dialysis fistulae
Thrombectomy with use of
the over-the-wire PTD
via access sheath
Post-PTD thrombectmy fistulogram
showing patent fistulae

For illustrative purposes only. Courtesy of Miloslav Rocek, MD, PhD, Institute for Clinical & Interventional Radiology (IKEM), Dept. of Diagnostic & Interventional Radiology Videnska 800, 14000 Prague 4 Czech Republic.


  1. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations. 2006 update. Am J Kidney Dis. 2006;48:1-322. 
  2. Trerotola, S.O., Vesely, T.M., Lund, G.B., Soulen, M.C., Ehrman, K.O., Cardella, J.F. Treatment of Thrombosed Hemodialysis Access Grafts: Arrow-Trerotola Percutaneous Thrombolytic Device Versus Pulse-Spray Thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial. Radiology. 1998; 206: 403-414.
  3. Lazzaro CR, Trerotola SO, Shah H, et al. Modified use of the Arrow-Trerotola Percutaneous Thrombolytic Device for the treatment of thrombosed hemodialysis access grafts. J of Vasc Interv Radiol. 1999;10:1025-1031. Dr. Trerotola  is a paid consultant and receives royalty payments from Teleflex Incorporated or its affiliates for the Arrow-Trerotola PTD® Percutaneous Thrombolytic Device. 
  4. Rocek M, Peregrin JH, Lasovickova J, et al. Mechanical thrombolysis of thrombosed hemodialysis native fistulas with use of the Arrow-Trerotola Percutaneous Thrombolytic Device: our preliminary experience. J of Vasc Interven Radiol. 2000;11:1153-1158. Dr. Rocek is a paid consultant of Teleflex Incorporated. 
  5. Lajvardi A, Trerotola SO, Strandberg JD, et al. Evaluation of venous injury case by percutaneous mechanical thrombolytic device. Cardiovasc Interv Radio. 1995;18:172-178. Dr. Trerotola  is a paid consultant and receives royalty payments from Teleflex Incorporated or its affiliates for the Arrow-Trerotola PTD® Percutaneous Thrombolytic Device. 
The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.

Practitioners must be aware of the device's contraindications as well as potential complications associated with percutaneous dialysis graft and AV fistulas thrombolysis including hemorrhage, symptomatic pulmonary embolism, arterial embolization, allergic reaction to contrast, and pseudoaneurysm.

The PTD device is not for use in stents.

Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions. Information in this material is not a substitute for the product Instructions for Use. Not all products are available in all regions. Please contact customer service to confirm availability in your region. Teleflex, the Teleflex logo, Arrow-Trerotola and PTD are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MCI-2020-0350